首页> 中文期刊>中国医疗前沿 >明胶海绵术前栓塞子宫动脉治疗Ⅱa期宫颈癌

明胶海绵术前栓塞子宫动脉治疗Ⅱa期宫颈癌

     

摘要

目的探讨Ⅱa期宫颈癌患者术前介入栓塞的临床意义。方法39例宫颈癌Ⅱa期患者术前行超选择性插管栓塞,3-7d后行宫颈癌根治术加放疗,分析其手术切除成功率、术中出血量及疗效,并与36例单纯手术加放疗患者进行对照。结果栓塞组临床症状均有不同程度的缓解,术中平均出血量300ml,明显低于单纯手术组的660ml;术中见瘤体有不同程度的坏死、缩小,分界变清,容易分离;病理示部分瘤细胞变性、坏死,瘤细胞数量减少。术前栓塞可减少术后复发率。结论子宫动脉栓塞是Ⅱa期宫颈癌术前有效的辅助治疗手段。%  Objective To study the clinical value of preoperative interventional embolization in stageⅡa cervical cancer. Methods 39 patients with stageⅡa cervical cancer underwent preoperative superselective catheterization embolization(embolism group) for 3-7days, then radical resection of cervical cancer were performed. The operative rate, intraoperative bleeding and therapeutic effects were analyzed. 36 cases underwent simple operation(control group). All the patients underwent Radiotherapy after radical resection 2-3 weeks. Results The clinical symptoms of the embolism group were relieved to different extent, and during the operation, the mean blood loss of which was 300ml, obviously lower than that of the control group, which was 660ml. In the embolism group the tumor body was necrosis, diminution, tumor boundary become clear and easy to separate from the normal tissue. In post-operative pathological examination, some tumor cells were degenerate and necrosis, the cell population was reduced. Recurrence of the embolism group is lower obviously. Conclusion Preoperative uterine artery embolization is an effective adjunctive therapy in stageⅡa cervical cancer.

著录项

相似文献

  • 中文文献
  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号